CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,206,202 | -24.9% | 62,694 | -2.2% | 0.02% | -26.9% |
| Q4 2022 | $2,938,299 | +18.0% | 64,127 | +24.8% | 0.03% | +8.3% |
| Q3 2022 | $2,490,000 | +24.7% | 51,400 | +1.2% | 0.02% | +26.3% |
| Q2 2022 | $1,996,000 | -37.1% | 50,812 | -41.1% | 0.02% | -44.1% |
| Q1 2022 | $3,173,000 | -28.3% | 86,208 | -11.2% | 0.03% | -32.0% |
| Q4 2021 | $4,424,000 | +20.9% | 97,071 | -5.2% | 0.05% | +42.9% |
| Q3 2021 | $3,658,000 | +95.6% | 102,354 | +8.3% | 0.04% | +105.9% |
| Q2 2021 | $1,870,000 | -37.5% | 94,492 | -26.6% | 0.02% | -41.4% |
| Q1 2021 | $2,992,000 | +13.0% | 128,652 | +1.0% | 0.03% | -3.3% |
| Q4 2020 | $2,648,000 | – | 127,438 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |